Letter to the Editor: Integrating the Roles of Pharmacy Practice and Drug Delivery in Mitigating COVID-19.
- Publisher:
- INNOVISION COMMUNICATIONS
- Publication Type:
- Journal Article
- Citation:
- Alternative therapies in health and medicine, 2020, 26, (S2), pp. 90-91
- Issue Date:
- 2020-08
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
ContentServer.asp(1).pdf | 121.01 kB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Prasher, P | |
dc.contributor.author | Sharma, M | |
dc.contributor.author | Singh, L | |
dc.contributor.author | Kumar Chellappan, D | |
dc.contributor.author | Shukla, S | |
dc.contributor.author | Pont, LG | |
dc.contributor.author | Williams, KA | |
dc.contributor.author |
Dua, K |
|
dc.date.accessioned | 2021-04-13T05:44:52Z | |
dc.date.available | 2021-04-13T05:44:52Z | |
dc.date.issued | 2020-08 | |
dc.identifier.citation | Alternative therapies in health and medicine, 2020, 26, (S2), pp. 90-91 | |
dc.identifier.issn | 1078-6791 | |
dc.identifier.issn | 1078-6791 | |
dc.identifier.uri | http://hdl.handle.net/10453/148058 | |
dc.description.abstract | No Abstract Available. | |
dc.format | ||
dc.language | eng | |
dc.publisher | INNOVISION COMMUNICATIONS | |
dc.relation.ispartof | Alternative therapies in health and medicine | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 1103 Clinical Sciences, 1104 Complementary and Alternative Medicine | |
dc.subject.classification | Complementary & Alternative Medicine | |
dc.subject.mesh | Betacoronavirus | |
dc.subject.mesh | Coronavirus Infections | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Pandemics | |
dc.subject.mesh | Pharmacy | |
dc.subject.mesh | Pneumonia, Viral | |
dc.subject.mesh | SARS-CoV-2 | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Pneumonia, Viral | |
dc.subject.mesh | Coronavirus Infections | |
dc.subject.mesh | Pharmacy | |
dc.subject.mesh | Pandemics | |
dc.subject.mesh | Betacoronavirus | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | SARS-CoV-2 | |
dc.subject.mesh | Betacoronavirus | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Coronavirus Infections | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Pandemics | |
dc.subject.mesh | Pharmacy | |
dc.subject.mesh | Pneumonia, Viral | |
dc.subject.mesh | SARS-CoV-2 | |
dc.title | Letter to the Editor: Integrating the Roles of Pharmacy Practice and Drug Delivery in Mitigating COVID-19. | |
dc.type | Journal Article | |
utslib.citation.volume | 26 | |
utslib.location.activity | United States | |
utslib.for | 1103 Clinical Sciences | |
utslib.for | 1104 Complementary and Alternative Medicine | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health | |
pubs.organisational-group | /University of Technology Sydney/Strength - CHSP - Health Services and Practice | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health/Graduate School of Health | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health/Graduate School of Health/GSH.Pharmacy | |
utslib.copyright.status | closed_access | * |
pubs.consider-herdc | false | |
dc.date.updated | 2021-04-13T05:44:51Z | |
pubs.issue | S2 | |
pubs.publication-status | Published | |
pubs.volume | 26 | |
utslib.citation.issue | S2 |
Abstract:
No Abstract Available.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph